Pemetrexed
- Product NDC
- 60505-6068
- 11-digit product format
- 605056068
- Labeler code
- 60505
- Product ID
- 60505-6068_bcc07a71-41ab-e25e-aaf6-79bd6a7d5f30
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pemetrexed disodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Apotex Corp
- Application
- ANDA209851
- Marketing category
- ANDA
- Marketing start
- 2022-05-25
- Marketing end
- 2026-06-30
- Substance
- PEMETREXED DISODIUM
- Active strength
- 750 mg/30mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pemetrexed
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PEMETREXED DISODIUM | 750 mg/30mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2PKU919BA9 |
| Rxcui | 2602136 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60505-6068-0 | Pemetrexed | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 5 |
| 60505-6068-0 | Pemetrexed | 30 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-6068 | PEMETREXED (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APOTEX CORP] | 5 | Current NDC, Legacy NDC, 2 package rows | 20241115_2e86f231-e0c7-2d43-2920-6c42d2469d11.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-6068-0 | 60505606800 | 1 VIAL in 1 CARTON (60505-6068-0) / 30 mL in 1 VIAL | 1 vial | 2022-05-25 | 2026-06-30 | No | No | Current |